Related Experiment Video

Updated: May 14, 2026

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
08:49

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes

Published on: March 14, 2021

Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell lines

Vincenza Rita Lo Vasco1, Martina Leopizzi, Caterina Chiappetta

  • 1Department of Sensitive Organs, Policlinic Umberto I, Faculty of Medicine and Odontoiatry, Sapienza University of Rome, viale del Policlinico 155, Rome, 00185, Italy, ritalovasco@hotmail.it.

Journal of Cell Communication and Signaling
|February 23, 2013
PubMed

Insights

Researchers identified the expression of Phosphoinositide-specific Phospholipase C (PI-PLC) enzymes in human osteosarcoma cell lines. This provides a comprehensive panel for studying PI signaling in osteosarcoma pathogenesis.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Osteosarcoma pathogenesis involves complex signal transduction pathways.
  • Intracellular calcium ions act as crucial second messengers regulating cell death.
  • Phosphoinositides (PI), particularly phosphatidylinositol (4,5)-bisphosphate (PIP2), are vital for cellular functions and are regulated by PI-PLC enzymes.

Purpose of the Study:

  • To delineate the expression profile of Phosphoinositide-specific Phospholipase C (PI-PLC) enzyme families in human osteosarcoma cell lines.
  • To establish a comprehensive expression panel of PI-PLC isoforms for future research.
  • To investigate the role of PI signaling in osteosarcoma.

Main Methods:

  • Analysis of PI-PLC enzyme expression in four human osteosarcoma cell lines (MG-63, 143B, SaOS-2, Hs888).
  • Utilizing cell culture and transcript analysis.
  • Administration of U-73122 to assess PI-PLC transcript level modifications.

Main Results:

  • A detailed expression panel of various PI-PLC isoforms (β1, β2, β3, β4, γ1, γ2, δ1, δ3, δ4, ε, η1) was identified across the studied osteosarcoma cell lines.
  • Specific isoforms were expressed in each cell line, with variations noted.
  • U-73122 treatment demonstrated a transient effect on PI-PLC transcript levels.

Conclusions:

  • The study successfully characterized the expression of PI-PLC isoforms in human osteosarcoma cell lines.
  • The generated expression panel serves as a valuable resource for functional studies.
  • Further research can now explore the specific roles of PI signaling pathways in osteosarcoma development and progression.

More Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...